Relationship between deficits in overall quality of life and non-small-cell lung cancer survival

Journal of Clinical Oncology

Volumn 30, Issue 13, 2012, Pages 1498-1504

  Sloan, Jeff A ^a   Zhao, Xinghua ^a   Novotny, Paul J ^a   Wampfler, Jason ^a   Garces, Yolanda ^a   Clark, Matthew M ^a   Yang, Ping ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGE; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; QUALITY OF LIFE; SCORING SYSTEM; SEX DIFFERENCE; SMOKING; AGED; LUNG TUMOR; MIDDLE AGED; MORTALITY; PROGNOSIS; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME; UNITED STATES;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MINNESOTA; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84862987721     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.33.4631     Document Type: Article

References (59)

1. Bezjak A, Tu D, Seymour L, et al: Symptom improvement in lung cancer patients treated with erlotinib: Quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR. 21. J Clin Oncol 24:3831-3837, 2006 (Pubitemid 46630729)
2. Bottomley A, Efficace F, Thomas R, et al: Health-related quality of life in non-small-cell lung cancer: Methodologic issues in randomized controlled trials. J Clin Oncol 21:2982-2992, 2003 (Pubitemid 46621851)
3. Lilenbaum RC, Cashy J, Hensing TA, et al: Prevalence of poor performance status in lung cancer patients: Implications for research. J Thorac Oncol 3:125-129, 2008 (Pubitemid 351323185)
4. Broberger E, Sprangers M, Tishelman C: Do internal standards of quality of life change in lung cancer patients? Nurs Res 55:274-282, 2006 (Pubitemid 44503659)
5. Brundage MD, Davidson JR, Mackillop WJ: Trading treatment toxicity for survival in locally advanced non-small cell lung cancer. J Clin Oncol 15:330-340, 1997 (Pubitemid 27020591)
6. Bergman B, Aaronson NK, Ahmedzai S, et al: The EORTC QLQ-LC13: A modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer 30A:635-642, 1994 (Pubitemid 24164250)
7. Cella D, Eton DT, Fairclough DL, et al: What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592. J Clin Epidemiol 55:265-295, 2002
8. Eton DT, Fairclough DL, Cella D, et al: Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: Results from Eastern Cooperative Oncology Group Study 5592. J Clin Oncol 21:1536-1543, 2003 (Pubitemid 46594107)
9. Efficace F, Bottomley A, Smit EF, et al: Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975. Ann Oncol 17:1698-1704, 2006 (Pubitemid 44680892)
10. Langendijk H, Aaronson NK, de Jong JM, et al: The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol 55:19-25, 2000 (Pubitemid 30219430)
11. Maione P, Perrone F, Gallo C, et al: Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: A prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol 23:6865-6872, 2005
12. Nowak AK, Stockler MR, Byrne MJ: Assessing quality of life during chemotherapy for pleural mesothelioma: Feasibility, validity, and results of using the European Organisation for Research and Treatment of Cancer Core Quality of Life Questionnaire and Lung Cancer Module. J Clin Oncol 22:3172-3180, 2004 (Pubitemid 41103732)
13. Claassens L, van Meerbeeck J, Coens C, et al: Health-related quality of life in non-small-cell lung cancer: An update of a systematic review on methodologic issues in randomized controlled trials. J Clin Oncol 29:2104-2120, 2011
14. Cooley ME: Symptoms in adults with lung cancer: A systematic research review. J Pain Symptom Manage 19:137-153, 2000
15. Dales RE, Bélanger R, Shamji FM, et al: Quality-of-life following thoracotomy for lung cancer. J Clin Epidemiol 47:1443-1449, 1994
16. Degner LF, Sloan JA: Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer. J Pain Symptom Manage 10:423-431, 1995
17. Finkelstein DM, Cassileth BR, Bonomi PD, et al: A pilot study of the Functional Living Index-Cancer (FLIC) scale for the assessment of quality of life for metastatic lung cancer patients: An Eastern Cooperative Oncology Group Study. Am J Clin Oncol 11:630-633, 1988
18. Ganz PA, Lee JJ, Siau J: Quality of life assessment: An independent prognostic variable for survival in lung cancer. Cancer 67:3131-3135, 1991
19. Gotay CC, Kawamoto CT, Bottomley A, et al: The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol 26:1355-1363, 2008
20. Quinten C, Coens C, Mauer M, et al: Baseline quality of life as a prognostic indicator of survival: A meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncology 10:865-871, 2009
21. Efficace F, Therasse P, Piccart MJ, et al: Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: An international multicenter study. J Clin Oncol 22:3381-3388, 2004 (Pubitemid 41103697)
22. Montazeri A, Milroy R, Hole D: Quality of life in lung cancer patients: As an important prognostic factor. Lung Cancer 31:233-240, 2001
23. Mauer M, Stupp R, Taphoorn MJ, et al: The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: Results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study. Br J Cancer 97:302-307, 2007
24. Tan AD, Novotny PJ, Kaur JS, et al: A patient-level meta-analytic investigation of the prognostic significance of baseline quality of life (QOL) for overall survival (OS) among 3,704 patients participating in 24 North Central Cancer Treatment Group (NCCTG) and Mayo Clinic Cancer Center (MC) oncology clinical trials. J Clin Oncol 26:505s, 2008 (suppl; abstr 9515)
25. Qi Y, Schild SE, Mandrekar SJ, et al: Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer. Thorac Oncol 4:1075-1082, 2009
26. Montazeri A: Quality of life data as prognostic indicators of survival in cancer patients: An overview of the literature from 1982 to 2008. Health Qual Life Outcomes 7:102, 2009
27. Sarna L, Padilla G, Holmes C, et al: Quality of life of long-term survivors of non-small-cell lung cancer. J Clin Oncol 20:2920-2929, 2002 (Pubitemid 34728885)
28. Farmer M, Case D, Lesser G, et al: A phase III double blind placebo controlled prospective randomized trial on the effect of megestrol acetate on weight and health-related quality of life in lung cancer and head/neck cancer patients receiving definitive radiation therapy. Int J Radiat Oncol Biol Physics 63:S77, 2005 (abstr)
29. Mountain CF: Revisions in the International System for Staging Lung Cancer. Chest 111:1710-1717, 1997
30. Geddes DM: Quality of life in lung cancer. Respir Med 85:7-11, 1991; discussion 33-37 (suppl B)
31. Garces YI, Yang P, Parkinson J, et al: The relationship between cigarette smoking and quality of life after lung cancer diagnosis. Chest 126:1733-1741, 2004 (Pubitemid 39643973)
32. Yang P, Allen MS, Aubry MC, et al: Clinical features of 5,628 primary lung cancer patients: Experience at Mayo Clinic from 1997-2003. Chest 128:452-462, 2005 (Pubitemid 40994510)
33. Clark MM, Novotny PJ, Patten CA, et al: Motivational readiness for physical activity and quality of life in long-term lung cancer survivors. Lung Cancer 61:117-122, 2008
34. Sugimura H, Yang P: Long-term survivorship in lung cancer: A review. Chest 129:1088-1097, 2006
35. Hollen PJ, Gralla RJ, Kris MG, et al: Normative data and trends in quality of life from the Lung Cancer Symptom Scale (LCSS). Support Care Cancer 7:140-148, 1999 (Pubitemid 29187561)
36. Hollen PJ, Gralla RJ, Kris MG, et al: A comparison of visual analogue and numerical rating scale formats for the Lung Cancer Symptom Scale (LCSS): Does format affect patient ratings of symptoms and quality of life? Qual Life Res 14:837-847, 2005 (Pubitemid 40576868)
37. Sloan JA, Dueck A, Frost MH, et al: Applying QOL assessments: Solutions for oncology clinical practice and research, part 1. Curr Prob Cancer 29:267-351, 2005
38. Sloan JA, Dueck A, Frost MH, et al: Applying QOL assessments: Solutions for oncology clinical practice and research, part 2. Curr Probl Cancer 30:235-331, 2006
39. Huschka MM, Mandrekar SJ, Schaefer PL, et al: A pooled analysis of quality of life measures and adverse events data in North Central Cancer Treatment Group lung cancer clinical trials. Cancer 109: 787-795, 2007 (Pubitemid 46233242)
40. Buchanan DR, O'Mara AM, Kelaghan JW, et al: Quality-of-life assessment in the symptom management trials of the National Cancer Institute- supported community clinical oncology program. J Clin Oncol 23:591-598, 2005 (Pubitemid 46224237)
41. Giorgi F, Cellerino R, Gramazio A, et al: Assessing quality of life in patients with cancer: A comparison of a visual-analogue and a categorical model. Am J Clin Oncol 19:394-399, 1996 (Pubitemid 26242240)
42. Ballatori E, Porzio G, Roila F, et al: Is there still a role for the uniscale assessment of quality of life? Tumori 93:78-81, 2007 (Pubitemid 46506533)
43. Sloan JA, Berk L, Roscoe J, et al: Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. J Clin Oncol 25:5070-5077, 2007 (Pubitemid 350232285)
44. Locke DE, Decker PA, Sloan JA, et al: Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients. J Pain Symptom Manage 34:628-638, 2007 (Pubitemid 350161248)
45. Ginns P, Barrie S: Reliability of single-item ratings of quality in higher education: A replication. Psychol Rep 95:1023-1030, 2004 (Pubitemid 40131955)
46. Zimmerman M, Ruggero CJ, Chelminski I, et al: Developing brief scales for use in clinical practice: The reliability and validity of single-item self-report measures of depression symptom severity, psychosocial impairment due to depression, and quality of life. J Clin Psychiatry 67:1536-1541, 2006 (Pubitemid 44787435)
47. Butt Z, Wagner LI, Beaumont JL, et al: Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practice. J Pain Symptom Manage 35:20-30, 2008
48. Belsey DA, Kuh E, Welsch RE: Regression Diagnostics. New York, NY, John Wiley & Sons, 1980
49. Sun Z, Aubry MC, Deschamps C, et al: Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: An analysis of 5,018 hospital- and 712 population-based cases. J Thorac Cardiovasc Surg 131:1014-1020, 2006
50. Visbal AL, Williams BA, Nichols FC 3rd, et al: Gender differences in non-small-cell lung cancer survival: An analysis of 4,618 patients diagnosed between 1997 and 2002. Ann Thorac Surg 78:209-215, 2004; discussion 215
51. Sloan JA, Dueck A: Issues for statisticians in conducting analyses and translating results for quality of life end points in clinical trials. J Biopharm Stat 14:73-96, 2004 (Pubitemid 38294753)
52. Movsas B, Moughan J, Sarna L, et al: Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: An analysis of RTOG 9801. J Clin Oncol 27:5816-5822, 2009
53. Jacot W, Colinet B, Bertrand D, et al: Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients. Ann Oncol 19:1458-1464, 2008
54. Bernhard J, Hürny C, Bacchi M, et al: Initial prognostic factors in small-cell lung cancer patients predicting quality of life during chemotherapy: Swiss Group for Clinical Cancer Res (SAKK). Br J Cancer 74:1660-1667, 1996 (Pubitemid 26386099)
55. Cooley ME: Quality of life in persons with non-small cell lung cancer: A concept analysis. Cancer Nurs 21:151-161, 1998
56. Fergusson RJ, Cull A: Quality of life measurement for patients undergoing treatment for lung cancer. Thorax 46:671-675, 1991
57. Coussens LM, Werb Z: Inflammation and cancer. Nature 420:860-867, 2002 (Pubitemid 36019639)
58. Cella D, Fallowfield LJ: Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy. Breast Cancer Res Treat 107:167-180, 2008 (Pubitemid 350265697)
59. Reimer T, Gerber B: Quality-of-life considerations in the treatment of early-stage breast cancer in the elderly. Drugs Aging 27:791-800, 2010